SELLAS Life Sciences Group (SLS) Stock
SELLAS Life Sciences Group (SLS) closed at $7.46 on Nov 16, 2026; its Tenet Score is 41 of 100 against 313 Healthcare peers.
35 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $7.46
- Nov 16, 2026
- Market cap
- $1.6B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 1.39 – 15.88
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 41/100
- Weak · 313 Healthcare peers
Industry: Drugs
SELLAS Life Sciences Group Inc scores 41/100. Weak. Strongest on financial health, value is the soft spot versus 313 Healthcare peers. Insufficient inputs: Tenet 41 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=313Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ~ Not-a-Value-Trap Gate
13F flows & insider trades land here.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunother…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Certara IncCERT | 48 | $1.8B |
| Stoke Therapeutics IncSTOK | 51 | $1.7B |
| Sarepta Therapeutics IncSRPT | 48 | $1.7B |
| Vir Biotechnology IncVIR | 54 | $1.7B |
| Nurix Therapeutics IncNRIX | 85 | $1.7B |
| uniQure N.V.QURE | 37 | $1.7B |
| ANI Pharmaceuticals IncANIP | 69 | $1.6B |
| Immunocore Holdings plcIMCR | 53 | $1.5B |
| Pacira BioSciences IncPCRX | 56 | $1.5B |
| Absci CorpABSI | 37 | $1.5B |
Common questions
What sector and industry is SELLAS Life Sciences Group in?
SELLAS Life Sciences Group is in the Healthcare sector and the Drugs industry.
What is SELLAS Life Sciences Group's Tenet Score?
SELLAS Life Sciences Group's Tenet Score is 41 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




